UnitedHealth Group Incorporated $UNH Shares Sold by NewEdge Advisors LLC

Key Points

• NewEdge Advisors LLC reduced its holdings in UnitedHealth Group by 0.9%, selling 1,120 shares during the first quarter, leaving them with 123,207 shares worth $64.53 million.
• A number of hedge funds have recently increased their positions in UnitedHealth Group, with Night Owl Capital Management boosting its holdings by 39.3% during the same period.
• UnitedHealth Group's quarterly earnings missed analysts' consensus estimates, reporting $4.08 earnings per share compared to an expected $4.45, despite revenue increasing 12.9% year-over-year.

NewEdge Advisors LLC lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 0.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 123,207 shares of the healthcare conglomerate's stock after selling 1,120 shares during the quarter. NewEdge Advisors LLC's holdings in UnitedHealth Group were worth $64,530,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of the company. Bayforest Capital Ltd raised its holdings in shares of UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after acquiring an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd boosted its holdings in UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after purchasing an additional 50 shares during the period. Copia Wealth Management bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $42,000. IAG Wealth Partners LLC purchased a new position in shares of UnitedHealth Group in the first quarter valued at about $42,000. Finally, Investment Management Corp VA ADV purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at about $44,000. Institutional investors own 87.86% of the company's stock.

Insider Activity

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the transaction, the chief executive officer directly owned 10,398 shares of the company's stock, valued at $3,171,390. This represents a 5.36% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 0.28% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of research analyst reports. Robert W. Baird restated an "underperform" rating and set a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Oppenheimer cut their target price on shares of UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 30th. Wolfe Research lowered their target price on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a research note on Tuesday, May 20th. Morgan Stanley decreased their price objective on shares of UnitedHealth Group from $342.00 to $325.00 and set an "overweight" rating for the company in a research note on Wednesday, August 20th. Finally, KeyCorp lowered their price target on shares of UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. Sixteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $354.86.

UnitedHealth Group Stock Performance

NYSE:UNH traded up $5.07 during midday trading on Monday, reaching $320.46. The stock had a trading volume of 17,541,354 shares, compared to its average volume of 12,809,192. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a fifty day simple moving average of $288.78 and a two-hundred day simple moving average of $372.56. The stock has a market cap of $290.23 billion, a P/E ratio of 13.88, a P/E/G ratio of 2.04 and a beta of 0.44.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. UnitedHealth Group's revenue was up 12.9% compared to the same quarter last year. During the same period last year, the business posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. The ex-dividend date is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.8%. UnitedHealth Group's payout ratio is presently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.